Replies to post #81548 on NanoViricides Inc (NNVC)

[BonelessCat]

When I get a moment, I'm going to repost some old DD on valuation of development stage biopharma start-ups. I think that might also clear up why a late-preclinical stage small-cap would be valued at more than $1 a share, a lot more, even though there are no earnings, yet. Some are stuck in the notion that biopharma start-ups can be valued the same way and using the same metrics as Saleen Automotive or Unisource Corp.

[NewMoney]

Money losing biotechs combined with criminal investigations, CEO's that email inside information to individual investors. usually adds up to disaster.

They always have one thing in common, some amazing magical gonna save the world cures all snake oil.

Red flags abound here.

That formation on the right side of the chart is a bear flag. This stock is about to take another dive.

Easy short money.